Japan’s Non-COVID Jab Market to Surpass 180 Billion Yen by 2030: Fuji Keizai

March 14, 2023
The Japanese market of major vaccines excluding COVID-19 products will expand to 188 billion yen in 2030, up 16.3% from 2021, Fuji Keizai predicts. The company’s report released on March 8 looked into Japan’s vaccine markets in the following categories:...read more